sysa1801
mAbexperimentalADC
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 16, 2021 (NCT05009966)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Claudin-18BINDING AGENT
CLDN18 binding agent
Chemistry & pharmacology
- Payload
- Monomethyl auristatin E
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05009966 | Phase 1 | Sep 16, 2021 | Chinese Academy of Medical Sciences, Shijiazhuang Pharma Group (CSPC) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Shijiazhuang Pharma Group (CSPC) | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1